Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,109 | -11,959 | -6,402 | -28,132 | -20 |
| Depreciation Amortization | 1,335 | 900 | 463 | 1,599 | N/A |
| Accounts payable and accrued liabilities | 194 | 952 | -285 | -1,103 | N/A |
| Other Working Capital | -4,058 | -3,046 | -2,415 | -500 | 2 |
| Other Operating Activity | 3,408 | 92 | 878 | 1,986 | 0 |
| Operating Cash Flow | $-20,230 | $-13,061 | $-7,761 | $-26,150 | $-18 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 32 | 39 | -12 | -281 | N/A |
| Investing Cash Flow | $32 | $39 | $-12 | $-281 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 14 |
| Debt Repayment | -3,750 | -1,875 | N/A | N/A | N/A |
| Common Stock Issued | 60,482 | 60,482 | N/A | N/A | N/A |
| Common Stock Repurchased | -6,319 | -5,517 | N/A | N/A | N/A |
| Financing Cash Flow | $50,413 | $53,090 | $N/A | $N/A | $14 |
| Beginning Cash Position | 25,566 | 25,566 | 25,566 | 57,773 | 5 |
| End Cash Position | 55,781 | 65,634 | 17,793 | 31,342 | 1 |
| Net Cash Flow | $30,215 | $40,068 | $-7,773 | $-26,431 | $-4 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,230 | -13,061 | -7,761 | -26,150 | -18 |
| Capital Expenditure | -23 | -16 | -12 | -281 | N/A |
| Free Cash Flow | -20,253 | -13,077 | -7,773 | -26,431 | -18 |